BioArctic collaborator Novartis terminates agreement

The termination is the result of a Novartis decision to discontinue the program, unrelated to BioArctic's BrainTransporter technology. BioArctic will retain the full USD 30…

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.sharecast.com)